Press Releases

Date	Title	Company
26-Sep-2023	Pet Diabetes Care Devices Market: Pioneering a Path to US$ 4.3 Billion by 2033 in Canine and Feline Health	MARKITWIRED
26-Sep-2023	ePharmacy Market: Digitally Dispensing Success, Envisaging a US$ 351.9 Billion Horizon by 2033	MARKITWIRED
26-Sep-2023	Injection Pen Market Meteoric Rise: Surpassing US$ 85.8 Billion by 2033	MARKITWIRED
26-Sep-2023	Epilepsy Monitoring Devices Envisioned Market: Unveiling the US$ 894.63 Million Vision by 2033	MARKITWIRED
26-Sep-2023	Joint Replacement Market: Paving the Way for Seamless Mobility, Setting Sights on a US$ 27 Billion Valuation by 2032	MARKITWIRED
26-Sep-2023	Craniofacial Implants Market: Illuminating the Facial Transformation Horizon, Aiming for US$ 114.9 Million by 2033	MARKITWIRED
26-Sep-2023	Ischemia Reperfusion Injury Treatment Market: Harmonizing Healing on a Path to US$ 1580 Million by 2033	MARKITWIRED
26-Sep-2023	Polpharma Biologics Announces Approval of Europe’s First and Only Biosimilar for Multiple Sclerosis - Tyruko® (Natalizumab)	B3C newswire
25-Sep-2023	Eckert & Ziegler Signs Strategically Important Agreement for the Supply of Lutetium-177 with POINT Biopharma	Eckert & Ziegler Strahlen- und Medizintechnik AG
25-Sep-2023	The Pershing Square Sohn Cancer Research Alliance Is Now Accepting Applications for Its 2024 Prize for Rising Leaders in Cancer Research	Businesswire
25-Sep-2023	FMI’s Revelation: Sustained Release Excipients Market to Achieve a Strong 6.8% CAGR by 2026	MARKITWIRED
25-Sep-2023	Appili Therapeutics Announces U.S. FDA Approval of LIKMEZ™ (ATI-1501) Metronidazole Oral Suspension	Businesswire
25-Sep-2023	Cell Line Development Market Soars with a 7.7% CAGR to Reach US$ 10.6 Billion by 2033 \| Reveals by FMI	MARKITWIRED
25-Sep-2023	Genmab Announces European Commission Approval of TEPKINLY® (epcoritamab) for Adults with Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)	Businesswire
25-Sep-2023	Extremity Tissue Expanders Market Report by FMI Reveals an Average CAGR of 6.3%, Reaching US$ 1.8 Billion by 2028	MARKITWIRED
25-Sep-2023	Biologic Excipients Market to Achieve US$ 1.7 Billion by 2028, Driven by a Consistent 3.4% CAGR \| FMI Analysis	MARKITWIRED
25-Sep-2023	Sygnature Discovery successfully identifies potent SHP2 degrader compounds in collaboration with UBE Corporation	Sygnature Discovery
25-Sep-2023	FMI Predicts 3.4% CAGR for Behavioral Health Market, Reaching US$ 156.3 Billion by 2028	MARKITWIRED
25-Sep-2023	Step by Step: FMI Unveils Gait Trainer Market’s Impressive Growth to Reach US$ 456.3 Million by 2028	MARKITWIRED
25-Sep-2023	North America’s Vision Care Market on a Spectacular Rise, Predicted to Hit US$ 100.72 Billion by 2026 \| FMI’s Revelation	MARKITWIRED